Veterinary Medicines

AURIZON VET

Authorised
  • Clotrimazole
  • Marbofloxacin
  • Dexamethasone acetate
Download as PDF

Product identification

Medicine name:
АУРИЗОН ВЕТ
AURIZON VET
Active substance:
  • Clotrimazole
  • Marbofloxacin
  • Dexamethasone acetate
Target species:
  • Dog
Route of administration:
  • Auricular use

Product details

Active substance and strength:
  • Clotrimazole
    10.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Marbofloxacin
    3.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Dexamethasone acetate
    0.90
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Ear drops, suspension
Withdrawal period by route of administration:
  • Auricular use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS02CA06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol
Responsible authority:
  • Bulgarian Agency For Food Safety
Authorisation number:
  • 0022-2407
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 6/05/2022
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 6/05/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."